Bkemv Interactions
There are 104 drugs known to interact with Bkemv (eculizumab), along with 5 disease interactions. Of the total drug interactions, 46 are major, 49 are moderate, and 9 are minor.
- View Bkemv disease interactions (5)
Medications known to interact with Bkemv
Note: Showing generic names only.
- abrocitinib
- adalimumab
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- ashwaganda
- atezolizumab
- avelumab
- azathioprine
- baricitinib
- bcg
- bcg vaccine
- belimumab
- bifidobacterium infantis
- bifidobacterium longum
- brewer's yeast
- canakinumab
- cat's claw
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- cholera vaccine, live
- cladribine
- cosibelimab
- crovalimab
- dengue vaccine
- denosumab
- deucravacitinib
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- durvalumab
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- infliximab
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- ipilimumab
- iptacopan
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- loncastuximab tesirine
- retifanlimab
- rilonacept
- ritlecitinib
- rituximab
- roflumilast
- rotavirus vaccine
- rozanolixizumab
- rubella virus vaccine
- ruxolitinib topical
- talimogene laherparepvec
- teriflunomide
- tislelizumab
- tofacitinib
- toripalimab
- tremelimumab
- typhoid vaccine, live
Bkemv disease interactions
There are 5 disease interactions with Bkemv (eculizumab) which include:
More about Bkemv (eculizumab)
- Bkemv consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Empaveli
Empaveli (pegcetacoplan) is an immunosuppressant that is given by subcutaneous (under the skin) ...
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Vyvgart
Vyvgart is used for myasthenia gravis to improve muscle weakness in adults whose myasthenia gravis ...
Fabhalta
Fabhalta is used to treat paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A ...
Neostigmine
Neostigmine is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Pyridostigmine
Pyridostigmine is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.